Likarda is a cell therapy company developing microencapsulated, biocompatible cell therapies from slow gelling hydrogels such as PEG and Hyaluronic Acids to overcome the failures of alginate. They hydrogels are already used in wound healing, cosmetics, dermal fillers, and joint viscosupplements, and are found to be advanced and biocompatible.
We've developed a number of formulations of the durable and degradable varieties, and we, ourselves, are working on indications such as diabetes and osteoarthritis. We're certainly open to partnering and investments to scale our programs or advance yours.
We've developed a number of formulations of the durable and degradable varieties, and we, ourselves, are working on indications such as diabetes and osteoarthritis. We're certainly open to partnering and investments to scale our programs or advance yours.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Missouri
Company HQ Country:
United States
Year Founded:
2012
Main Therapeutic Focus:
Gene/Cell Therapy
Lead Product in Development:
Cell Delivery Technology for Diabetes
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
